| RS1553159979 |
AHDC1
|
Health Risk |
Pathogenic |
AHDC1-related intellectual disability - obstructive sleep apnea - mild dysmorphism syndrome, AHDC1-related intellectual disability - obstructive sleep apnea - mild dysmorphism syndrome |
| RS1553160126 |
DOCK7
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, 23 |
| RS1553160504 |
SLC6A9
|
Health Risk |
Likely pathogenic |
— |
| RS1553162317 |
MMACHC
|
Health Risk |
Pathogenic |
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, cblC TYPE |
| RS1553162601 |
POMGNT1
|
Health Risk |
Likely pathogenic |
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A3 |
| RS1553162663 |
POMGNT1
|
Health Risk |
Pathogenic |
Muscular dystrophy-dystroglycanopathy (congenital with intellectual disability), type B3 |
| RS1553162786 |
MMACHC
|
Health Risk |
Pathogenic |
Cobalamin C disease, Cobalamin C disease |
| RS1553162788 |
MMACHC
|
Health Risk |
Likely pathogenic |
Cobalamin C disease, Cobalamin C disease |
| RS1553162821 |
MMACHC
|
Health Risk |
Pathogenic/Likely pathogenic |
Cobalamin C disease, Cobalamin C disease |
| RS1553162857 |
MMACHC
|
Health Risk |
Likely pathogenic |
Cobalamin C disease, Cobalamin C disease |
| RS1553162868 |
MMACHC
|
Health Risk |
Likely pathogenic |
Cobalamin C disease, Cobalamin C disease |
| RS1553162872 |
POMGNT1
|
Health Risk |
Pathogenic |
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A3 |
| RS1553162873 |
POMGNT1
|
Health Risk |
Likely pathogenic |
Muscular dystrophy-dystroglycanopathy (congenital with intellectual disability), type B3 |
| RS1553162901 |
MMACHC
|
Health Risk |
Likely pathogenic |
Cobalamin C disease, Cobalamin C disease |
| RS1553162910 |
MMACHC
|
Health Risk |
Pathogenic/Likely pathogenic |
Cobalamin C disease, Cobalamin C disease |
| RS1553162918 |
MMACHC
|
Health Risk |
Pathogenic |
Cobalamin C disease, Cobalamin C disease |
| RS1553162923 |
MMACHC
|
Health Risk |
Pathogenic/Likely pathogenic |
Cobalamin C disease, Cobalamin C disease |
| RS1553162931 |
MMACHC
|
Health Risk |
Likely pathogenic |
Cobalamin C disease, Cobalamin C disease |
| RS1553162934 |
MMACHC
|
Health Risk |
Pathogenic/Likely pathogenic |
Cobalamin C disease, Cobalamin C disease |
| RS1553162937 |
MMACHC
|
Health Risk |
Likely pathogenic |
Cobalamin C disease, Cobalamin C disease |
| RS1553162943 |
MMACHC
|
Health Risk |
Likely pathogenic |
Cobalamin C disease, Cobalamin C disease |
| RS1553163077 |
POMGNT1
|
Health Risk |
Likely pathogenic |
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A3 |
| RS1553163123 |
DOCK7
|
Health Risk |
Likely pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS1553163206 |
POMGNT1
|
Health Risk |
Pathogenic |
Muscular dystrophy-dystroglycanopathy (congenital with intellectual disability), type B3 |
| RS1553163254 |
POMGNT1
|
Health Risk |
Likely pathogenic |
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A3 |
| RS1553163335 |
POMGNT1
|
Health Risk |
Likely pathogenic |
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A3 |
| RS1553163360 |
POMGNT1
|
Health Risk |
Pathogenic |
Muscular dystrophy-dystroglycanopathy (congenital with intellectual disability), type B3 |
| RS1553163534 |
POMGNT1
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive limb-girdle muscular dystrophy type 2O, Muscular dystrophy-dystroglycanopathy (congenital with intellectual disability) |
| RS1553163590 |
POMGNT1
|
Health Risk |
Likely pathogenic |
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A3 |
| RS1553163721 |
POMGNT1
|
Health Risk |
Likely pathogenic |
Muscular dystrophy-dystroglycanopathy (congenital with intellectual disability), type B3 |
| RS1553163920 |
POMGNT1
|
Health Risk |
Pathogenic |
— |
| RS1553164129 |
POMGNT1
|
Health Risk |
Likely pathogenic |
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A3 |
| RS1553165199 |
KCNQ4
|
Health Risk |
Pathogenic |
Autosomal dominant nonsyndromic hearing loss 2A, Autosomal dominant nonsyndromic hearing loss 2A |
| RS1553166135 |
PPT1
|
Health Risk |
Likely pathogenic |
Neuronal ceroid lipofuscinosis 1, Neuronal ceroid lipofuscinosis 1 |
| RS1553166147 |
PPT1
|
Health Risk |
Likely pathogenic |
Neuronal ceroid lipofuscinosis 1, Neuronal ceroid lipofuscinosis 1 |
| RS1553166337 |
PPT1
|
Health Risk |
Pathogenic |
Neuronal ceroid lipofuscinosis 1, Neuronal ceroid lipofuscinosis 1 |
| RS1553166499 |
PPT1
|
Health Risk |
Pathogenic |
Neuronal ceroid lipofuscinosis 1, Neuronal ceroid lipofuscinosis 1 |
| RS1553167415 |
PPT1
|
Health Risk |
Pathogenic |
Neuronal ceroid lipofuscinosis 1, Neuronal ceroid lipofuscinosis 1 |
| RS1553167430 |
PPT1
|
Health Risk |
Likely pathogenic |
Neuronal ceroid lipofuscinosis 1, Neuronal ceroid lipofuscinosis 1 |
| RS1553167474 |
PPT1
|
Health Risk |
Pathogenic |
Neuronal ceroid lipofuscinosis 1, Neuronal ceroid lipofuscinosis 1 |
| RS1553167479 |
PPT1
|
Health Risk |
Likely pathogenic |
Neuronal ceroid lipofuscinosis 1, Neuronal ceroid lipofuscinosis 1 |
| RS1553167616 |
KIF1B
|
Health Risk |
Conflicting classifications of pathogenicity |
Charcot-Marie-Tooth disease type 2, Charcot-Marie-Tooth disease type 2 |
| RS1553167851 |
NFIA
|
Health Risk |
Pathogenic |
— |
| RS1553167863 |
PPT1
|
Health Risk |
Likely pathogenic |
Neuronal ceroid lipofuscinosis 1, PPT1-related disorder |
| RS1553168601 |
KCNQ4
|
Health Risk |
Likely pathogenic |
Rare genetic deafness, Rare genetic deafness |
| RS1553168726 |
PIK3CD
|
Health Risk |
Pathogenic |
Immunodeficiency 14, Immunodeficiency 14 |
| RS1553168850 |
CPT2
|
Health Risk |
Likely pathogenic |
Carnitine palmitoyl transferase II deficiency, severe infantile form |
| RS1553169106 |
CPT2
|
Health Risk |
Likely pathogenic |
Carnitine palmitoyl transferase II deficiency, severe infantile form |
| RS1553169598 |
CPT2
|
Health Risk |
Likely pathogenic |
Carnitine palmitoyl transferase II deficiency, severe infantile form |
| RS1553169629 |
CPT2
|
Health Risk |
Pathogenic/Likely pathogenic |
Carnitine palmitoyl transferase II deficiency, severe infantile form |
| RS1553169666 |
CPT2
|
Health Risk |
Pathogenic |
Carnitine palmitoyl transferase II deficiency, severe infantile form |
| RS1553169716 |
CPT2
|
Health Risk |
Pathogenic |
Carnitine palmitoyl transferase II deficiency, severe infantile form |
| RS1553169720 |
CPT2
|
Health Risk |
Likely pathogenic |
Carnitine palmitoyl transferase II deficiency, severe infantile form |
| RS1553169726 |
CPT2
|
Health Risk |
Likely pathogenic |
Carnitine palmitoyl transferase II deficiency, severe infantile form |
| RS1553169771 |
CPT2
|
Health Risk |
Likely pathogenic |
Carnitine palmitoyl transferase II deficiency, severe infantile form |
| RS1553169787 |
CPT2
|
Health Risk |
Likely pathogenic |
Carnitine palmitoyl transferase II deficiency, severe infantile form |
| RS1553169799 |
CPT2
|
Health Risk |
Pathogenic |
Carnitine palmitoyl transferase II deficiency, severe infantile form |
| RS1553169813 |
CPT2
|
Health Risk |
Pathogenic/Likely pathogenic |
Carnitine palmitoyl transferase II deficiency, severe infantile form |
| RS1553169973 |
CPT2
|
Health Risk |
Pathogenic/Likely pathogenic |
Carnitine palmitoyl transferase II deficiency, severe infantile form |
| RS1553169975 |
CPT2
|
Health Risk |
Pathogenic |
Carnitine palmitoyltransferase II deficiency, Carnitine palmitoyltransferase II deficiency |
| RS1553170005 |
CPT2
|
Health Risk |
Likely pathogenic |
Carnitine palmitoyl transferase II deficiency, severe infantile form |
| RS1553170006 |
CPT2
|
Health Risk |
Conflicting classifications of pathogenicity |
Carnitine palmitoyl transferase II deficiency, severe infantile form |
| RS1553170029 |
CPT2
|
Health Risk |
Pathogenic/Likely pathogenic |
Carnitine palmitoyl transferase II deficiency, severe infantile form |
| RS1553170033 |
CPT2
|
Health Risk |
Likely pathogenic |
Carnitine palmitoyl transferase II deficiency, severe infantile form |
| RS1553170279 |
LDLRAP1
|
Health Risk |
Pathogenic |
Hypercholesterolemia, familial |
| RS1553171141 |
MTOR
|
Health Risk |
Pathogenic |
Inborn genetic diseases, CEBALID syndrome |
| RS1553172687 |
GRHL3
|
Health Risk |
Pathogenic |
Van der Woude syndrome 2, Van der Woude syndrome 2 |
| RS1553172962 |
DVL1
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal dominant Robinow syndrome 2, Autosomal dominant Robinow syndrome 2 |
| RS1553173356 |
DVL1
|
Health Risk |
Likely pathogenic |
— |
| RS1553173367 |
DVL1
|
Health Risk |
Likely pathogenic |
Autosomal dominant Robinow syndrome 2, Autosomal dominant Robinow syndrome 2 |
| RS1553173368 |
DVL1
|
Health Risk |
Likely pathogenic |
Autosomal dominant Robinow syndrome 2, Autosomal dominant Robinow syndrome 2 |
| RS1553173372 |
DVL1
|
Health Risk |
Likely pathogenic |
Autosomal dominant Robinow syndrome 2, Autosomal dominant Robinow syndrome 2 |
| RS1553173393 |
PLEKHG5
|
Health Risk |
Conflicting classifications of pathogenicity |
Neuronopathy, distal hereditary motor |
| RS1553173420 |
DVL1
|
Health Risk |
Pathogenic/Likely pathogenic |
Autosomal dominant Robinow syndrome 2, Autosomal dominant Robinow syndrome 2 |
| RS1553173425 |
DVL1
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS1553174500 |
PLEKHG5
|
Health Risk |
Likely pathogenic |
Glioma susceptibility 1, Glioma susceptibility 1 |
| RS1553174566 |
PLEKHG5
|
Health Risk |
Pathogenic/Likely pathogenic |
Neuronopathy, distal hereditary motor |
| RS1553174650 |
PRDM16
|
Health Risk |
Conflicting classifications of pathogenicity |
Left ventricular noncompaction 8, Inborn genetic diseases |
| RS1553174844 |
LEPR
|
Health Risk |
Pathogenic |
Obesity due to leptin receptor gene deficiency, Obesity due to leptin receptor gene deficiency |
| RS1553175089 |
SLC9A1
|
Health Risk |
Likely pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS1553175760 |
PLEKHG5
|
Health Risk |
Pathogenic |
Spinal muscular atrophy, facioscapulohumeral type |
| RS1553176765 |
PRDM16
|
Health Risk |
Likely pathogenic |
— |
| RS1553176976 |
SDHB
|
Health Risk |
Likely pathogenic |
Pheochromocytoma/paraganglioma syndrome 4, Pheochromocytoma |
| RS1553176979 |
SDHB
|
Health Risk |
Likely pathogenic |
Gastrointestinal stromal tumor, Pheochromocytoma |
| RS1553177267 |
SDHB
|
Health Risk |
Likely pathogenic |
Pheochromocytoma/paraganglioma syndrome 4, Gastrointestinal stromal tumor |
| RS1553177285 |
SDHB
|
Health Risk |
Pathogenic |
Pheochromocytoma, Gastrointestinal stromal tumor |
| RS1553177290 |
SDHB
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Pheochromocytoma |
| RS1553177292 |
SDHB
|
Health Risk |
Likely pathogenic |
Hereditary cancer-predisposing syndrome, Pheochromocytoma/paraganglioma syndrome 4 |
| RS1553177424 |
SDHB
|
Health Risk |
Pathogenic/Likely pathogenic |
Gastrointestinal stromal tumor, Pheochromocytoma/paraganglioma syndrome 4 |
| RS1553177436 |
SDHB
|
Health Risk |
Pathogenic |
Pheochromocytoma/paraganglioma syndrome 4, Gastrointestinal stromal tumor |
| RS1553177440 |
SDHB
|
Health Risk |
Pathogenic |
Gastrointestinal stromal tumor, Pheochromocytoma |
| RS1553177666 |
SDHB
|
Health Risk |
Pathogenic/Likely pathogenic |
Pheochromocytoma/paraganglioma syndrome 4, Gastrointestinal stromal tumor |
| RS1553177667 |
SDHB
|
Health Risk |
Likely pathogenic |
Pheochromocytoma, Gastrointestinal stromal tumor |
| RS1553177669 |
SDHB
|
Health Risk |
Pathogenic |
Pheochromocytoma, Gastrointestinal stromal tumor |
| RS1553177672 |
SDHB
|
Health Risk |
Pathogenic |
Hereditary pheochromocytoma and paraganglioma, Hereditary pheochromocytoma and paraganglioma |
| RS1553177676 |
SDHB
|
Health Risk |
Pathogenic |
Gastrointestinal stromal tumor, Pheochromocytoma |
| RS1553177677 |
SDHB
|
Health Risk |
Pathogenic |
Pheochromocytoma, Gastrointestinal stromal tumor |
| RS1553177678 |
SDHB
|
Health Risk |
Pathogenic |
Gastrointestinal stromal tumor, Pheochromocytoma |
| RS1553177679 |
SDHB
|
Health Risk |
Pathogenic |
Hereditary pheochromocytoma and paraganglioma, Hereditary pheochromocytoma and paraganglioma |
| RS1553177687 |
SDHB
|
Health Risk |
Pathogenic |
Hereditary pheochromocytoma and paraganglioma, Hereditary pheochromocytoma and paraganglioma |